Journals / Türk Biyokimya Dergisi / 2006 / Cilt: 31 - Sayı: 4

Benzoylcholine, indole-3-acetic and human serum butyrylcholinesterase interactions

Benzoyilkolin, indol-3-asetik asit ve insan serum butirilkolinesterazı etkileşimleri

Pages
182–186
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This difference in kinetic behavior with regards to two different substrates could arise from the tighter binding of the more bulky and hydrophobic benzoyl group to the hydrophobic pocket of the active site gorge rather than the butyryl group and that the binding of this butyryl group could be sterically hindered by the indole-3-acetic acid.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study we studied the kinetic interaction of indole-3- acetic acid with human serum butyrylcholinesterase.
📊
Key Findings & Data:The enzyme had a Km value of 14.22 ± 2.97 μM.
💡
Conclusion & Impact:This difference in kinetic behavior with regards to two different substrates could arise from the tighter binding of the more bulky and hydrophobic benzoyl group to the hydrophobic pocket of the active site gorge rather than the butyryl group and that the binding of this butyryl group could be sterically hindered by the indole-3-acetic acid.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study we studied the kinetic interaction of indole-3- acetic acid with human serum butyrylcholinesterase. Butyrylcholinesterase was purified from human serum and the benzoylcholine kinetics was analyzed. The enzyme had a Km value of 14.22 ± 2.97 μM. The Hill plot was linear with a value of nH = 0.95, displaying that the enzyme follows Michaelis-Menten kinetics with regard to benzoylcholine. Through inhibition studies, indole-3-acetic acid was found to be a noncompetitive inhibitor for human serum butyrylcholinesterase with benzoylcholine as substrate. The Ki value was calculated as 1.86 ± 0.27 mM. In our previous study on human serum butyrylcholinesterase using butyrylthiocholine as substrate, indole-3-acetic acid was found to be a linear-mixed type inhibitor. This difference in kinetic behavior with regards to two different substrates could arise from the tighter binding of the more bulky and hydrophobic benzoyl group to the hydrophobic pocket of the active site gorge rather than the butyryl group and that the binding of this butyryl group could be sterically hindered by the indole-3-acetic acid.

Özet

Çalışmamızda insan serum butirilkolinesterazı ile indol-3-asetik asidin kinetik etkileşimini incelemeyi amaçladık. İnsan serumundan saflaştırılan butirilkolin-esteraz ile substrat olarak benzoyilkolin kullanılarak yapılan kinetik incelemelerde Km değeri 14.22 ± 2.97 μM olarak hesaplandı. Doğrusal bir Hill grafiği elde edildi ve Hill sabiti nH = 0.95 olarak belirlendi. Bu sonuçlara göre enzim, substrat olarak benzoyilkolin ile Michaelis-Menten kinetiğine uyan bir davranış göstermektedir. Artan benzoyilkolin derişimleri varlığında yapılan inhibisyon çalışmaları ile, indol-3-asetik asidin etki mekanizmasının nonkompetetif tipte inhibisyon olduğu saptandı ve non-lineer regresyon analizi ile Ki değeri 1.86 ± 0.27 mM bulundu. Daha önce butirilkolinesteraz ve indol-3-asetik asit ile yaptığımız bir çalışmada, substrat olarak butiriltiyokolin kullanıldığında indol-3- asetik asidin lineer karışık tipte inhibitör davranışı gösterdiğini tespit edilmiştir. İki substratın farklı kinetik davranış göstermesinin nedeni, butiril gruba kıyasla daha büyük hidrofobik hacim kaplayan benzoyil grubun aktif merkezdeki hidrofobik cebe daha güçlü bağlanması, buna karşılık butiril grubun bağlanmasının indol-3- asetik tarafından engellenmesi olduğu söylenebilir.

🔖

Cite This Article

ÇOKUĞRAŞ, A. N., BODUR, E. (2022). Benzoylcholine, indole-3-acetic and human serum butyrylcholinesterase interactions. Türk Biyokimya Dergisi, Cilt: 31 - Sayı: 4, 182–186. https://ajindex.com/articles/621412

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Massoulie J, Pezzementi L, Bon S, Krejci E, Valette FM. (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41: 31–91
  2. Brown SS, Kallow W, Pilz W, Whittaker M, Woronick CL. (1981) The plasma cholinesterases: A new perspective. Adv Clin Chem 22: 1 – 123
  3. Rhynäen RJJ. (1983) Pseudocholinesterase activity in some body fluids. Gen Pharmacol 14: 459 – 460
  4. Ashani Y, Shapiro S, Levy D, Wolfe AD, Doctor BP, Raveh L. (1991) Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 41: 37–41
  5. Giacobini E. (2000) Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy. In: Cholinesterases and Cholinesterase Inhibitors (E. Giacibini, Ed.), pp. 181–226. Martin Dunitz Ltd.,London
  6. Somani SM, Dube SN. (1989) Physostigmine—an overview as pretreatment drug for organophosphate intoxication. Int J Clin Pharmacol Ther Toxicol. 27 (8):367-87 [7] Wallace LMA (1998) Medical Management of Glaucoma. The New England Journal of Medicine (NEMJ) 339: 1298-1307
  7. Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Satomura Y, Arimura K, Osame M, Hattori T; The Study Group for Myasthenia Gravis in Japan. (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J Neurol Sci. 224 (1-2):43-7
  8. Normanly J, and Bartel B, Redundancy as a way of life–IAA metabolism, Curr Opin Plant Biol 2, 207 (1999)
  9. Greco AV, Mingrone G, Favuzzi A, Bertuzzi A, Gandolfi A, DeSmet R, Vanholder R, Gasbarrini G. (2000) Subclinical hepatic encephalopathy: role of tryptophan binding to albumin and the competition with indole-3-acetic acid. J Investig Med 48 (4):274-80
  10. Anderson GM, Gerner RH, Cohen DJ, Fairbanks L. (1984) Central tryptamine turnover in depression, schizophrenia, and anorexia: measurement of indole acetic acid in cerebrospinal fluid. Biol Psychiatry 19 (10):1427-35
  11. Antoshechkin AG, Zuyeva LA, Maximova LA. (1988) Excretion of phenylpyruvic, 4-hydroxyphenylpyruvic and indolyl- 3-acetic acids by the skin fibroblasts from a phenylketonuric child. J Inherit Metab Dis. 11:299-301
  12. Folkes LK, Candeias LP, Wardman P. (1998) Toward targeted “oxidation therapy” of cancer: peroxidase-catalysed cytotoxicity of indole-3-acetic acids. Int J Radiat Oncol Biol Phys. 42 (4):917-20
  13. Çokuğraş AN, Bodur E. (2003) Comparative effects of two plant growth regulators; indol-3-acetic acid and chlorogenic acid on human an